Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
|Articles|August 31, 2020
New practice risks post COVID-19
Author(s)Lindsey Carr, Editor
Although everyone is eager to return to normal, it is important that it is done safely.
Advertisement
Reopening decisions are happening across the country, and it is important to consider certain facets to ensure a safe opening for providers and patients.
In a recent interview with Karin Torpey Bashaw, Vice President of Patient Safety and Risk Management with The Doctors Company, Medical Economics discusses how physicians can prepare to reopen and manage risks in the new normal.
Advertisement
Related to this article
Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.
Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.
Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Maternal high egg and peanut intake in pregnancy and lactation did not lower infant IgE-mediated egg or peanut allergy at 1 year in PrEggNut.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves pritelivir tablets to treat lesions from HSV
2
Perimenopause and mental health: Beyond hormonal vs psychological
3
HPV vaccine before pregnancy tied to fewer adverse pregnancy outcomes
4
Ultrasound findings after medication management of early pregnancy loss
5